Business / Finance

RSS

Cortex enters agreement with Biovail to regain AMPAKINE assets and rights

Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL, a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc., to regain the AMPAKINE® assets and rights related to respiratory depression.

16 Mar 2011

TSO3 revenue decreases to $7.7 million for fiscal year ending December 31, 2010

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, today reported sales for the fiscal year ending December 31, 2010 totalling $939,285 representing the sale of four new generation sterilizers to 3M for training purposes.

16 Mar 2011

Prism Medical receives new UK contract to provide Disability Equipment Services

Prism Medical Ltd., a leading provider of durable medical equipment and related services to the mobility disadvantaged, today announced that the Company has been awarded a significant new contract to provide Disability Equipment Services for the London Borough of Bexley.

16 Mar 2011

China Nepstar Chain Drugstore fourth quarter revenues increase 1.0% to US$95 million

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2010.

16 Mar 2011

Almac invests in two ZED automated inline wallet presses

Global Clinical Services provider Almac has announced an investment in two ZED automated inline wallet presses. Operating in Craigavon and Pennsylvania, the fully automated machines will drastically reduce timelines associated with the use of blister card packaging, when compared with current rotary press methods.

16 Mar 2011

Sonova expects sales of around CHF 1,600 million for the current business year 2010/11

Sonova Holding AG, the world's leading provider of hearing systems, is announcing today that the Group is expecting sales of around CHF 1,600 million and an EBITA margin of 20-21% for 2010/11, barring any unforeseen events.

16 Mar 2011

Wound Management reviews alternatives to return to OTCBB

Wound Management Technologies, Inc., a leader in advanced wound care solutions, today commented on the shift in the Company's stock quotation coverage which recently transitioned from the OTCBB to the OTCQB under the symbol "WNDM."

16 Mar 2011

NMS announces license agreement with Novartis

Nerviano Medical Sciences, the largest pharmaceutical R&D facility in Italy and one of the leading oncology-focused, integrated discovery and development companies in Europe, today announced a license agreement with Novartis.

16 Mar 2011

Raymond Associates, BioNeutral enter global sales and distribution agreement for Ygiene antimicrobial technology

BioNeutral Group, Inc., a specialty life science technology-based company, today announced that it has entered into a global sales and distribution agreement with Raymond Associates LLC, a Service Connected Certified Disabled Veteran-Owned Business and executive management consulting firm.

15 Mar 2011

Omeros fourth quarter net loss increases to $7.2 million

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced financial results for the fourth quarter and year ended December 31, 2010.

15 Mar 2011

DJO Global signs definitive agreement to purchase Rikco for $254.6 million

DJO Global, Inc., a leading provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that one of its indirect subsidiaries has signed a definitive agreement to purchase Rikco International, LLC, D/B/A Dr. Comfort, for approximately $254.6 million in cash.

15 Mar 2011

BioDrain retains CFSG1 as its U.S. Investor Relations representative

BioDrain Medical, Inc., producer of the FDA cleared Streamway System for automated surgical fluid disposal, announced today that it has retained Consulting for Strategic Growth 1 as its U.S. Investor Relations representative.

15 Mar 2011

ShangPharma fourth quarter net revenues increase 29.4% to $25.6 million

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its financial results for its fourth quarter and the fiscal year ended December 31, 2010.

15 Mar 2011

Illumina prices 0.25% Convertible Senior Notes due 2016

Illumina, Inc. today announced the pricing of $800 million principal amount of 0.25% Convertible Senior Notes due 2016 through offerings to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

From Illumina, Inc. 15 Mar 2011

Medidata fourth quarter net revenue is $47.4 million for 2010

Medidata Solutions, a leading global provider of SaaS-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the fourth quarter 2010 and full year ended December 31, 2010, as well as provided financial guidance for the first quarter and full year 2011.

15 Mar 2011

Hanger Orthopedic Group amends existing Credit Agreement

Hanger Orthopedic Group, Inc. announced today that it has amended its existing Credit Agreement to lower the applicable interest rates and modify certain other covenants. The Amendment (i) reduces the interest rate margin applicable to the term loan under the Credit Agreement by 0.75% to 3.00% and (ii) reduces the LIBOR floor applicable to the term loan under the Credit Agreement from 1.50% to 1.00%.

14 Mar 2011

BioMed declares $0.20 first quarter dividend

BioMed Realty Trust, Inc. today announced that its board of directors has declared a first quarter 2011 dividend of $0.20 per share of common stock, representing a 17.6% increase over the company's fourth quarter 2010 dividend of $0.17 per share. The dividend is equivalent to an annualized dividend of $0.80 per common share.

14 Mar 2011

Milestone Scientific commences trading on OTCQB

Milestone Scientific Inc. which develops, manufactures, and markets computer-controlled injection systems for medical and dental markets, today announced that its common stock has commenced trading on the OTCQB(TM) electronic quotation and trading system under the ticker symbol MLSS.PK. Stockholders are not required to take any action as a result of the addition of the Company's securities to the OTCQB(TM).

14 Mar 2011

Air Techniques' Spectra device leads caries detection aid category in sales

Air Techniques, Inc., a leading dental equipment manufacturer, announced today that its Spectra device led the caries detection aid category in dollar sales with a 2010 market share of almost 50%. In addition, in the fourth quarter of 2010, Spectra for the first time also led the category in units sold, and it set a record with a dollar market share of over 60%.

14 Mar 2011

Gamida to distribute Health Robotics' CytoCare, i.v.STATION, i.v.SOFT technologies in Israel

Health Robotics today announced that it recently signed an exclusive distribution agreement for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies with Israel-based medical technology leader Gamida MedEquip Ltd.

14 Mar 2011